HCEMM-SU Molecular Oncohematology Research Group

Bence Bátai

Bence Bátai

EDUCATION

  • 2015- Semmelweis University, Faculty of Medicine, Budapest
  • 2009-2015 Piarist Grammar School, Budapest

RESEARCH EXPERIENCE

  • 2017-  Hungarian Academy of Sciences –Semmelweis University Momentum Molecular Oncohematology Research Group, 1stDepartment of Pathology and Experimental Cancer Research, Semmelweis University
  • 2016-2017 Hungarian Academy of Sciences –Semmelweis University Pathobiochemistry Research Group, DepartmentofMedicalChemistry,MolecularBiologyandPathobiochemistry, Semmelweis University
 

CLINICAL EXPERIENCE

  • 2016- Clinical work in Anesthesiology and Intensive Care, Department of Transplantation and Surgery, Semmelweis University, BudapestMEMBERSHIPSANDCOMMUNITY2020Head-organizer of the 2ndSemmelweis Talent Conference
  • 2019-Student Representative of theCouncil of theScientific Students’ Association, Semmelweis University
  • 2019- Member of the Hungary Chapter of the Hungarian Medical Association of America
  • 2019 Organizer of the 1st Semmelweis Talent Conference
  • 2018-2019
  • Member of the Scientific Committee of the Frigyes Korányi Collegefor Advanced Studies
  • 2017-Frigyes Korányi College for Advanced Studies
  • 2017-Rector’s Excellency List of Semmelweis University
  • 2017-Ödön Kerpel-Fronius Talent Support Program
 

SCHOLARSHIPS AND AWARDS

  • 2020- New National Excellence Program of the Ministry for Innovation and Technology, Hungary
  • 2020 National Higher Education Grant, Hungarian Ministry of Human Capacities
  • 2019-Complementary Research Excellence Program(MD-PhD Program)of Károly Rácz School of PhD Studies, Semmelweis University, Budapest
  • 2019-2020New National Excellence Program of the Ministry for Innovation and Technology, Hungary–Terminal evaluation of project: Excellent
  • 2019 Kerpel Talent Awardby the Ödön Kerpel-Fronius TalentSupport Program
  • 2019 Blessed László Awardby the László Batthyány-StrattmannMedical
  • Association
 

LANGUAGES

English: advanced level, Cambridge CAE C1 complex language exam (2014)
Spanish: intermediate level, Cervantes DELE B2 complex language exam (2016)
 

PUBLICATIONS

Pub

8. Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma.

Nagy, Á., Bátai, B.,Balogh, A., Illés, S., Mikala, G.,Nagy, N., Kiss, L.,Kotmayer, L., Matolcsy, A.,Alpár, D., Masszi, T., Masszi, A., BödörCs.  Genes (Basel) 2020 Jul 13; 11(7): E785. IF: 3.76 (2019)

Pub

7. Juvenile myelomonocytic leukaemia presentation after preceding juvenile xanthogranuloma harbouring an identical somatic PTPN11 mutation.

Bátai, B.,Krizsán, Sz., Gángó,A.,Hegyi, L., Csóka, M., Erdélyi, D.J., Csomor, J., Kállay, K., Bödör, Cs.  Pediatric Blood & Cancer 2020 Jun 18;e28368. IF: 2.36 (2019)

Pub

6. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.

Gango, A.*, Batai, B.*, Varga, M., Kapczar, D., Papp, G., Marschalko, M., Kuroli, E., Schneider, T., Csomor, J., Matolcsy, A., Bodor, C., Szepesi, A. Virchows Archiv 2018, 473(4): 453-462. IF: 2.86(2018).*These two authors contributed equally to this work

Pub

5. Molecular subtypes and genomicprofile of primary central nervous system lymphoma.

Bödör, Cs., Alpár, D., Marosvári, D., Galik, B., Rajnai, H., Bátai, B.,Nagy, Á., Kajtár, B., Burján, A., Deák, B., Schneider, T., Alizadeh, H., Matolcsy, A., Brandner, S., Storhoff, J., Chen, N., Liu, M.D.,Ghali, N., Csala, I., Bagó G., A., Gyenesei, A., Reiniger L.  Accepted to Journal of Neuropathology and Experimental Neurology IF: 3.46 (2018)

Pub

4. Potential applications of liquid biopsy analyses in oncohematology[Hungarian]

Ákos Nagy, Bence Bátai, LauraKiss, AnitaMarx, László ImrePinczés, GergőPapp, ImreKacskovics, DonátAlpár, CsabaBödör, Hematológia-Transzfuziológia 2020, 53(3): 144-156

Pub

3. New perspective in the personalized medicine of follicular lymphoma –Targeting the EZH2 histon methyltransferase. [Hungarian]

Bence Bátai, Dóra Lévai, Júlia Gaál-Weisinger, Alexandra Balogh, Ambrus Gángó, Csaba Bödör, Noémi Nagy.Hematológia-Transzfuziológia 2018, 51(2): 61-70.

Pub

2.  Screening for genomic copy number alterations in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification.[Hungarian]

RichárdKiss, Gergő Papp, SzilviaKrizsán, LiliKotmayer, AmbrusGángó, NoémiNagy, BenceBátai, Zoltán Mátrai, Csaba Bödör, Donát Alpár. Hematológia-Transzfuziológia 2018, 51(1): 31-40.

Pub

1. The genetic background of primary cutaneous follicular lymphoma[Hungarian]

Bence Bátai  Rector’s Thesis Contest, 1st prize

 ENGLISH POSTER PRESENTATIONS

Pub

Ákos Nagy, Bence Bátai, Alexandra Balogh, Sarolta Illés, András Masszi, Donát Alpár, Csaba BödörLiquid Biopsy-Based Monitoring of Ezh2 Mutations in Follicular Lymphoma:Implications for Non-Invasive Disease Monitoring and Targeted TherapyOnline Semmelweis 250 Clinical Conference, 9-10 November 2020

Pub

Bence Bátai, Ákos Nagy, Alexandra Balogh, Sarolta Illés, András Masszi, Donát Alpár, Csaba BödörLiquid Biopsy-Based Monitoring of EZH2 Mutations in Follicular Lymphoma: Implications for Non-Invasive Disease Monitoring and Targeted TherapyOnline conference of the Hungarian Medical Association of America, 28-29August 2020

Pub

Bence Bátai, Noémi Nagy, Ambrus Gángó, Ákos Nagy, Csaba Bödör EZH2 mutation screening in Hungarian follicular lymphoma patients: paving the way to epigenetic therapy.Conference of the Hungarian Medical Association of America, Balatonfüred, 30-31 August 2019

HUNGARIAN POSTER PRESENTATIONS

Pub

Bence Bátai, Szilvia Krizsán, Ambrus Gángó, Noémi Nagy, Monika Csóka, Dániel János Erdélyi, Krisztián Kállay, Judit Csomor, Csaba BödörJuvenile myelomonocytic leukaemia presentation after preceding juvenile xanthogranuloma harbouring an identical somatic PTPN11 mutation[Hungarian]XXVII. Conference of the Hungarian Hematology and Transfusiology Association, Pécs, 23-25 May 2019

Pub

Bence Bátai EZH2 mutation screening in Hungarian follicular lymphoma patients: paving the way to epigenetic therapy[Hungarian] XXIV. Frigyes Korányi Science Forum, Budapest, 21-22March2019,Clinicaloncologyand oncodiagnostics: 2ndprize

This website uses cookies. For more information visit the Cookies & Privacy Policy page.
Skip to content